Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia

Author: Hallez Sophie   Simon Philippe   Maudoux Frédéric   Doyen Jean   Noël Jean-Christophe   Beliard Aude   Capelle Xavier   Buxant Frédéric   Fayt Isabelle   Lagrost Anne-Cécile   Hubert Pascale   Gerday Colette   Burny Arsène   Boniver Jacques   Foidart Jean-Michel   Delvenne Philippe   Jacobs Nathalie  

Publisher: Springer Publishing Company

ISSN: 0340-7004

Source: Cancer Immunology, Immunotherapy, Vol.53, Iss.7, 2004-07, pp. : 642-650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content